IDO1 and acute myeloid leukemia: As displayed in Figure 3(a), we testified that CCL1, CH3IL1, IDO1, MMP9, and TNFSF15 were observably upregulated, and SH2DA1 and ZNF264 were signally downregulated in DC-CIK cells from AML patients relative to that in normal patients.